serine has been researched along with gsk 2334470 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alessi, DR; Najafov, A; Shpiro, N | 1 |
1 other study(ies) available for serine and gsk 2334470
Article | Year |
---|---|
Akt is efficiently activated by PIF-pocket- and PtdIns(3,4,5)P3-dependent mechanisms leading to resistance to PDK1 inhibitors.
Topics: Amino Acid Sequence; Animals; Binding Sites; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Drug Resistance, Neoplasm; Enzyme Activation; HEK293 Cells; Humans; Indazoles; Mechanistic Target of Rapamycin Complex 2; Mice; Molecular Sequence Data; Multiprotein Complexes; Mutation; Neoplasms; Phosphatidylinositol Phosphates; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Recombinant Proteins; Ribosomal Protein S6 Kinases; Serine; TOR Serine-Threonine Kinases | 2012 |